Research ExplorerPublicationsA clinically relevant gene signature in triple negative and ...

A clinically relevant gene signature in triple negative and basal-like breast cancer.

Standard

A clinically relevant gene signature in triple negative and basal-like breast cancer. / Rody, Achim; Karn, Thomas; Liedtke, Cornelia; Pusztai, Lajos; Ruckhaeberle, Eugen; Hanker, Lars; Gaetje, Regine; Solbach, Christine; Ahr, Andre; Metzler, Dirk; Schmidt, Marcus; Müller, Volkmar; Holtrich, Uwe; Kaufmann, Manfred.

In: BREAST CANCER RES, Vol. 13, No. 5, 5, 2011, p. 97.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Rody, A, Karn, T, Liedtke, C, Pusztai, L, Ruckhaeberle, E, Hanker, L, Gaetje, R, Solbach, C, Ahr, A, Metzler, D, Schmidt, M, Müller, V, Holtrich, U & Kaufmann, M 2011, 'A clinically relevant gene signature in triple negative and basal-like breast cancer.', BREAST CANCER RES, vol. 13, no. 5, 5, pp. 97. https://doi.org/10.1186/bcr3035

APA

Rody, A., Karn, T., Liedtke, C., Pusztai, L., Ruckhaeberle, E., Hanker, L., Gaetje, R., Solbach, C., Ahr, A., Metzler, D., Schmidt, M., Müller, V., Holtrich, U., & Kaufmann, M. (2011). A clinically relevant gene signature in triple negative and basal-like breast cancer. BREAST CANCER RES, 13(5), 97. [5]. https://doi.org/10.1186/bcr3035

Vancouver

Rody A, Karn T, Liedtke C, Pusztai L, Ruckhaeberle E, Hanker L et al. A clinically relevant gene signature in triple negative and basal-like breast cancer. BREAST CANCER RES. 2011;13(5):97. 5. https://doi.org/10.1186/bcr3035

Bibtex

@article{5b7a864178ab4e81b3dcb7bad253287c,
title = "A clinically relevant gene signature in triple negative and basal-like breast cancer.",
abstract = "Current prognostic gene expression profiles for breast cancer mainly reflect proliferation status and are most useful in ER-positive cancers. Triple negative breast cancers (TNBC) are clinically heterogeneous and prognostic markers and biology-based therapies are needed to better treat this disease.",
author = "Achim Rody and Thomas Karn and Cornelia Liedtke and Lajos Pusztai and Eugen Ruckhaeberle and Lars Hanker and Regine Gaetje and Christine Solbach and Andre Ahr and Dirk Metzler and Marcus Schmidt and Volkmar M{\"u}ller and Uwe Holtrich and Manfred Kaufmann",
year = "2011",
doi = "10.1186/bcr3035",
language = "English",
volume = "13",
pages = "97",
journal = "BREAST CANCER RES",
issn = "1465-5411",
publisher = "BioMed Central Ltd.",
number = "5",

}

RIS

TY - JOUR

T1 - A clinically relevant gene signature in triple negative and basal-like breast cancer.

AU - Rody, Achim

AU - Karn, Thomas

AU - Liedtke, Cornelia

AU - Pusztai, Lajos

AU - Ruckhaeberle, Eugen

AU - Hanker, Lars

AU - Gaetje, Regine

AU - Solbach, Christine

AU - Ahr, Andre

AU - Metzler, Dirk

AU - Schmidt, Marcus

AU - Müller, Volkmar

AU - Holtrich, Uwe

AU - Kaufmann, Manfred

PY - 2011

Y1 - 2011

N2 - Current prognostic gene expression profiles for breast cancer mainly reflect proliferation status and are most useful in ER-positive cancers. Triple negative breast cancers (TNBC) are clinically heterogeneous and prognostic markers and biology-based therapies are needed to better treat this disease.

AB - Current prognostic gene expression profiles for breast cancer mainly reflect proliferation status and are most useful in ER-positive cancers. Triple negative breast cancers (TNBC) are clinically heterogeneous and prognostic markers and biology-based therapies are needed to better treat this disease.

U2 - 10.1186/bcr3035

DO - 10.1186/bcr3035

M3 - SCORING: Journal article

VL - 13

SP - 97

JO - BREAST CANCER RES

JF - BREAST CANCER RES

SN - 1465-5411

IS - 5

M1 - 5

ER -